ResearcherNankai UniversityNo recent work listed

Wei Wei

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6440-7972; OpenAlex author ID A5100323734. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2014: 2 papers

Papers 2

The roles of Wnt5a, JNK and paxillin in the occurrence of metastasis of pancreatic adenocarcinoma. First author DOI 10.1007/s10147-013-0648-0 ↗
WNT5A modulates cell cycle progression and contributes to the chemoresistance in pancreatic cancer cells. Co-author DOI 10.1016/s1499-3872(14)60277-0 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xiaohong Shen · 1 shared paper, 2014 · strength 0.05
- Paper The roles of Wnt5a, JNK and paxillin in the occurrence of metastasis of pancreatic adenocarcinoma. DOI 10.1007/s10147-013-0648-0 ↗
Wenli Lu · 1 shared paper, 2014 · strength 0.05
- Paper The roles of Wnt5a, JNK and paxillin in the occurrence of metastasis of pancreatic adenocarcinoma. DOI 10.1007/s10147-013-0648-0 ↗
Xiao-Hong Shen · 1 shared paper, 2014 · strength 0.05
- Paper WNT5A modulates cell cycle progression and contributes to the chemoresistance in pancreatic cancer cells. DOI 10.1016/s1499-3872(14)60277-0 ↗
Qiang Li · 1 shared paper, 2014 · strength 0.05
- Paper WNT5A modulates cell cycle progression and contributes to the chemoresistance in pancreatic cancer cells. DOI 10.1016/s1499-3872(14)60277-0 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.